Westside Investment Management’s Pulse Biosciences PLSE Stock Holding History

Westside Investment Management’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.16M	Buy	77,768 +7,276	+10%	+$172K	0.28%	89
2026 Q1	$1.52M	Buy	70,492 +4,166	+6%	+$76.9K	0.23%	104
2025 Q4	$911K	Buy	66,326 +1,886	+3%	+$29.4K	0.15%	128
2025 Q3	$1.14M	Buy	64,440 +150	+0.2%	+$2.37K	0.18%	114
2025 Q2	$970K	Buy	64,290 +6,135	+11%	+$102K	0.18%	116
2025 Q1	$936K	Buy	58,155 +3,034	+6%	+$56.6K	0.2%	113
2024 Q4	$960K	Buy	55,121 +125	+0.2%	+$2.2K	0.2%	115
2024 Q3	$965K	Sell	54,996 -8,604	-14%	-$147K	0.21%	118
2024 Q2	$712K	Buy	63,600 +31,440	+98%	+$296K	0.16%	126
2024 Q1	$280K	Sell	32,160 -2,015	-6%	-$18.5K	0.07%	194
2023 Q4	$418K	Sell	34,175 -24,583	-42%	-$170K	0.11%	154
2023 Q3	$237K	Sell	58,758 -11,377	-16%	-$70.7K	0.07%	189
2023 Q2	$504K	Sell	70,135 -40,966	-37%	-$262K	0.14%	134
2023 Q1	$373K	Sell	111,101 -27,508	-20%	-$83K	0.11%	156
2022 Q4	$383	Sell	138,609 -6,114	-4%	-$13.7K	﹤0.01%	291
2022 Q3	$332	Sell	144,723 -33,472	-19%	-$54.4K	﹤0.01%	306
2022 Q2	$272	Buy	178,195 +52,166	+41%	+$131K	﹤0.01%	309
2022 Q1	$612	Buy	126,029 +91,367	+264%	+$748K	﹤0.01%	285
2021 Q4	$513	Buy	34,662 +525	+2%	+$10.5K	﹤0.01%	280
2021 Q3	$737	Buy	34,137 +228	+0.7%	+$4.91K	﹤0.01%	264
2021 Q2	$556	Buy	33,909 +1,541	+5%	+$29.3K	﹤0.01%	264
2021 Q1	$766	Buy	32,368 +906	+3%	+$27.1K	﹤0.01%	246
2020 Q4	$750	Sell	31,462 -2,146	-6%	-$34.1K	﹤0.01%	207
2020 Q3	$396	Sell	33,608 -2,113	-6%	-$22.7K	﹤0.01%	232
2020 Q2	$373	Buy	35,721 +8,661	+32%	+$78K	﹤0.01%	212
2020 Q1	$193	Buy	+27,060	New	+$281K	﹤0.01%	238
2019 Q2	$273K	Buy	+20,650	New	+$282K	0.1%	132
2018 Q4	$201K	Sell	17,525 -2,500	-12%	-$30.2K	0.07%	156
2018 Q3	$245K	Buy	20,025 +2,600	+15%	+$36.9K	0.08%	132
2018 Q2	$278K	Buy	17,425 +2,150	+14%	+$36.4K	0.1%	131
2018 Q1	$214K	Buy	+15,275	New	+$290K	0.12%	150

Other funds holding PLSE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Westside Investment Management's PLSE Position: Q2 2026 in Review

Westside Investment Management increased its Pulse Biosciences (PLSE) stake by 10% in Q2 2026, buying an estimated $172K and bringing the position to 77,768 shares worth $2.16M. The position accounts for 0.28% of the portfolio, ranked #89.

Westside Investment Management first reported a position in PLSE in Q1 2018 and has held it in 31 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

Westside Investment Management held 77,768 shares of Pulse Biosciences worth $2.16M as of Q2 2026.
Westside Investment Management bought 7,276 Pulse Biosciences shares in Q2 2026, an estimated $172K.
Pulse Biosciences made up 0.28% of Westside Investment Management's portfolio in Q2 2026, its #89 holding.
Westside Investment Management first reported a position in Pulse Biosciences in Q1 2018 and has held it in 31 quarters since.
106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.